Tumor mutational burden
Tumour mutational burden (abbreviated as TMB) is a genetic characteristic of tumorous tissue that can be informative to cancer research and treatment. It is defined as the number of non-inherited mutations per million bases (Mb) of investigated genomic sequence, and its measurement has been enabled by next generation sequencing. TMB has shown potential as a predictive biomarker with several applications, including associations reported between different TMB levels and patient response to immune checkpoint inhibitor (ICI) therapy in a variety of cancers.
primaryTopic
Tumor mutational burden
Tumour mutational burden (abbreviated as TMB) is a genetic characteristic of tumorous tissue that can be informative to cancer research and treatment. It is defined as the number of non-inherited mutations per million bases (Mb) of investigated genomic sequence, and its measurement has been enabled by next generation sequencing. TMB has shown potential as a predictive biomarker with several applications, including associations reported between different TMB levels and patient response to immune checkpoint inhibitor (ICI) therapy in a variety of cancers.
has abstract
Tumour mutational burden (abbr ...... use based on TMB measurements.
@en
Link from a Wikipage to an external page
Wikipage page ID
66,880,796
page length (characters) of wiki page
Wikipage revision ID
1,022,648,298
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
comment
Tumour mutational burden (abbr ...... erapy in a variety of cancers.
@en
label
Tumor mutational burden
@en